Patents by Inventor Tony Tung-Yin LEE

Tony Tung-Yin LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230338431
    Abstract: Disclosed herein are human hepatocytes for example isolated human hepatic progenitor cells, artificial tissue or organ thereof, and kits or compositions thereof. Also disclosed herein are various methods of using a human hepatocyte disclosed herein.
    Type: Application
    Filed: April 12, 2023
    Publication date: October 26, 2023
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE, Eing-Mei TSAI
  • Publication number: 20230321190
    Abstract: Disclosed are pharmaceutical or cosmetic compositions comprising secretomes, for example secreted proteins from stem cells, and uses thereof. A composition that contains a secretome and an acceptable excipient may be free of a cell. The compositions are useful for inducing an immune response, treating an inflammatory response, treating a microbial infection, differentiating cells, wound healing, embryonic development, placental development, central nervous system development, or morphogenesis.
    Type: Application
    Filed: October 19, 2022
    Publication date: October 12, 2023
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE
  • Publication number: 20230140717
    Abstract: Disclosed herein are mortal pluripotent stem cells produced in vitro and compositions thereof. Disclosed herein are methods of treating a disorder or condition by utilizing the cells disclosed herein. Also disclosed herein are methods of growing cells in culture medium as well as populations of mortal pluripotent stem cells differentiated therefrom.
    Type: Application
    Filed: October 12, 2022
    Publication date: May 4, 2023
    Inventors: Jau-Nan Lee, Tony Tung-Yin LEE, Yuta LEE
  • Publication number: 20210355436
    Abstract: Disclosed herein are precursory regulatory cytotrophoblast cells produced in vitro and compositions thereof. Disclosed herein are isolated populations of precursory regulatory cytotrophoblast cells, where the cells are produced in vitro. Disclosed herein are genetically engineered cells. Also disclosed herein are methods of treating a disorder or condition by utilizing the cells disclosed herein.
    Type: Application
    Filed: June 14, 2021
    Publication date: November 18, 2021
    Inventors: Jau-Nan LEE, Yuta LEE, Tony Tung-Yin LEE
  • Publication number: 20210330713
    Abstract: Disclosed herein are human hepatocytes for example isolated human hepatic progenitor cells, artificial tissue or organ thereof, and kits or compositions thereof. Also disclosed herein are various methods of using a human hepatocyte disclosed herein.
    Type: Application
    Filed: April 29, 2021
    Publication date: October 28, 2021
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE, Eing-Mei TSAI
  • Publication number: 20210254015
    Abstract: Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.
    Type: Application
    Filed: April 28, 2021
    Publication date: August 19, 2021
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE
  • Patent number: 11085019
    Abstract: Disclosed herein are precursory regulatory cytotrophoblast cells produced in vitro and compositions thereof. Also disclosed herein are methods of treating a disorder or condition by utilizing the cells disclosed herein.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: August 10, 2021
    Assignee: ACCELERATED BIOSCIENCES CORP.
    Inventors: Jau-Nan Lee, Yuta Lee, Tony Tung-Yin Lee
  • Patent number: 11028366
    Abstract: Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: June 8, 2021
    Assignee: Accelerated BioSciences Corp.
    Inventors: Jau-Nan Lee, Tony Tung-Yin Lee, Yuta Lee
  • Patent number: 11026979
    Abstract: Disclosed herein are human hepatocytes for example isolated human hepatic progenitor cells, artificial tissue or organ thereof, and kits or compositions thereof. Also disclosed herein are various methods of using a human hepatocyte disclosed herein.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: June 8, 2021
    Assignee: ACCELERATED BIOSCIENCES CORP.
    Inventors: Jau-Nan Lee, Tony Tung-Yin Lee, Yuta Lee, Eing-Mei Tsai
  • Publication number: 20200354672
    Abstract: Disclosed herein are precursory regulatory cytotrophoblast cells produced in vitro and compositions thereof. Also disclosed herein are methods of treating a disorder or condition by utilizing the cells disclosed herein.
    Type: Application
    Filed: May 7, 2020
    Publication date: November 12, 2020
    Inventors: Jau-Nan LEE, Yuta LEE, Tony Tung-Yin LEE
  • Publication number: 20200345788
    Abstract: Disclosed herein are human hepatocytes for example isolated human hepatic progenitor cells, artificial tissue or organ thereof, and kits or compositions thereof. Also disclosed herein are various methods of using a human hepatocyte disclosed herein.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 5, 2020
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE, Eing-Mei TSAI
  • Patent number: 10765704
    Abstract: Disclosed herein are induced hepatocytes from a trophoblast stem cell, methods for inducing the cells, and compositions thereof. Also disclosed herein are methods of treating a disease or disorder (e.g., liver-associated) by utilizing an induced hepatocyte disclosed herein.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: September 8, 2020
    Assignee: ACCELERATED BIOSCIENCES CORP.
    Inventors: Jau-Nan Lee, Tony Tung-Yin Lee, Yuta Lee, Eing-Mei Tsai
  • Publication number: 20190211311
    Abstract: Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.
    Type: Application
    Filed: March 22, 2019
    Publication date: July 11, 2019
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE
  • Patent number: 10294458
    Abstract: Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: May 21, 2019
    Assignee: ACCELERATED BIOSCIENCES CORP.
    Inventors: Jau-Nan Lee, Tony Tung-Yin Lee, Yuta Lee
  • Publication number: 20180000868
    Abstract: Disclosed herein are induced hepatocytes from a trophoblast stem cell, methods for inducing the cells, and compositions thereof. Also disclosed herein are methods of treating a disease or disorder (e.g., liver-associated) by utilizing an induced hepatocyte disclosed herein.
    Type: Application
    Filed: September 15, 2017
    Publication date: January 4, 2018
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE, Eing-Mei TSAI
  • Patent number: 9808490
    Abstract: Disclosed herein are induced hepatocytes from a trophoblast stem cell, methods for inducing the cells, and compositions thereof. Also disclosed herein are methods of treating a disease or disorder (e.g., liver-associated) by utilizing an induced hepatocyte disclosed herein.
    Type: Grant
    Filed: November 25, 2015
    Date of Patent: November 7, 2017
    Assignee: ACCELERATED BIOSCIENCES CORP.
    Inventors: Jau-Nan Lee, Tony Tung-Yin Lee, Yuta Lee, Eing-Mei Tsai
  • Publication number: 20170067024
    Abstract: Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.
    Type: Application
    Filed: August 18, 2016
    Publication date: March 9, 2017
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE
  • Patent number: 9457053
    Abstract: Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: October 4, 2016
    Assignee: ACCELERATED BIOSCIENCES CORP.
    Inventors: Jau-Nan Lee, Tony Tung-Yin Lee, Yuta Lee
  • Publication number: 20160199416
    Abstract: Disclosed herein are induced hepatocytes from a trophoblast stem cell, methods for inducing the cells, and compositions thereof. Also disclosed herein are methods of treating a disease or disorder (e.g., liver-associated) by utilizing an induced hepatocyte disclosed herein.
    Type: Application
    Filed: November 25, 2015
    Publication date: July 14, 2016
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta LEE, Eing-Mei TSAI
  • Publication number: 20140170118
    Abstract: Provided herein are methods of differentiating stem cells via modulating miR-124, and the differentiated cells thereby. Also provided herein are methods for the treatment of diseases using the differentiated cells.
    Type: Application
    Filed: November 26, 2013
    Publication date: June 19, 2014
    Applicant: Accelerated BioSciences Corp.
    Inventors: Jau-Nan LEE, Tony Tung-Yin LEE, Yuta Lee